Your VoC Programme is underperforming – and you know it.
This paper is not to convince you that you should have a Voice of the Customer (VoC) program. It’s 2020 – we assume you have this by now. If not, please let us know if you need arguments to convince your manager, we will help you.
However, 50% of all Voice of the Customer practitioners are unhappy with their programme1.
Fred Reichheld, the creator of the Net Promoter System, claims that 70% of companies do NPS wrong. And too many VoC programmes that we at Futurelab have ever encountered are struggling to reach their full potential or present a substantial ROI. Given the current focus on ROI in the evaluation of VoC (and in the broader sense CX) programmes, this is a dangerous position to find yourself.
In this paper, we show you the key steps you must take to ensure the success of your VoC programme – whether it is based on NPS, CES or other metrics.
Only logged in customers who have purchased this product may leave a review.
You may also like
The future of work is at the heart of every major socio-economic-political debate raging around the world today. All of these discussions – be they about walls across borders, migrants landing on the beaches of Southern Europe, surveillance policies in Xinjiang, hard or soft Brexits, taxi services in Paris or the concentration of wealth among the 1% – are rooted in the topic of the nature and distribution of work. From work, and what is derived from it – money –comes power.
21 More Jobs of the Future$0.00 Cognizant
Demographic change, geopolitical turbulence and macroeconomic uncertainty. Disruptive technologies and exploding data volumes. Shifting regulatory requirements. An increasingly complex matrix of competitors, partners and vendors. The financial services industry faces an unprecedented quantum of change — one that will only expand and accelerate.
Moving from analog to digital$0.00 EY
Artificial intelligence (AI) has the potential to transform the pharmaceutical industry. Each of the major pharma players is investing in the technology at some level, and there are a growing number of applications that address target and drug discovery, preclinical and clinical development, and postapproval activities.
Artificial Intelligence in Life Sciences$0.00 LEK
Trouble with Conavigo
Want to refine your results?
Help with Sourcing
Need help with your Sourcing?